SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : GUMM - Eliminate the Common Cold

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: DanZ who wrote (4339)5/7/2003 2:46:04 PM
From: StockDung  Read Replies (1) of 5582
 
Dan, No funds will ever buy MTXX/GUMM. The "research" you speak of is a joke, no serious fund of any kind pays attention to schlock firms like Edgewater. "The door" will not be "opened" rather it is forever closed considering what MTXX/GUMM is: a POS taken public as a unit deal by Kensington Securities (which see, was long ago put to rest by the SEC) and touted by Gunn Allen, the last of the Florida pump and dump shops that is just waiting for the same fate as KENS

2) No other "analysts" will be writing up MTXX/GUMM unless the Company pays them to as they have in the past.

3) MTXX is, according the 10K a "homeopathic products company" To say or imply anything different if fraudulent and a misrepresentation of the Company. In other words Dan, your BS about Biotoech could cost you and the company. You really don't want that to happen do you?

Don't you think it's kid nof funny Dan that whenever MTXX goes sideways or down for a while that some new PR or BS research just happens to come out?
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext